Composite weak vector bosons in a left-right symmetric preon model

por Sekiguchi, M, Ishida, S, Wada, H
Publicado 1995

Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma

por Sonobe, M, Manabe, T, Wada, H, Tanaka, F
Publicado 2005

Mass spectra and wave functions of meson systems and the covariant oscillator quark model as an expansion basis

por Oda, R, Yamada, K, Ishida, S, Sekiguchi, M, Wada, H
Publicado 1999

Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients

por Ogawa, E, Takenaka, K, Yanagihara, K, Kurozumi, M, Manabe, T, Wada, H, Tanaka, F
Publicado 2004

High mobility group box 1: as a 'testament' mediator

por Maruyama, I, Abeyama, K, Ito, T, Biswas, KK, Kawahara, K, Hashiguchi, T, Yakabe, K, Yamada, S, Wada, H
Publicado 2005

Evaluations of biomarkers associated with 5-FU sensitivity for non-small-cell lung cancer patients postoperatively treated with UFT

por Nakano, J, Huang, C, Liu, D, Masuya, D, Nakashima, T, Yokomise, H, Ueno, M, Wada, H, Fukushima, M
Publicado 2006

Apoptosis and p53 status predict the efficacy of postoperative administration of UFT in non-small cell lung cancer

por Tanaka, F, Otake, Y, Yanagihara, K, Yamada, T, Miyahara, R, Kawano, Y, Li, M, Inui, K, Wada, H
Publicado 2001

Liver resection with thrombectomy for patients with hepatocellular carcinoma and tumour thrombus in the inferior vena cava or right atrium

por Matsukuma, S., Eguchi, H., Wada, H., Noda, T., Shindo, Y., Tokumitsu, Y., Matsui, H., Takahashi, H., Kobayashi, S., Nagano, H.
Publicado 2020

Alteration of p16 and p15 genes in human uterine tumours

por Nakashima, R, Fujita, M, Enomoto, T, Haba, T, Yoshino, K, Wada, H, Kurachi, H, Sasaki, M, Wakasa, K, Inoue, M, Buzard, G, Murata, Y
Publicado 1999

MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells

por Tomimaru, Y, Eguchi, H, Nagano, H, Wada, H, Tomokuni, A, Kobayashi, S, Marubashi, S, Takeda, Y, Tanemura, M, Umeshita, K, Doki, Y, Mori, M
Publicado 2010

Insulin-like growth factor-binding protein 7 alters the sensitivity to interferon-based anticancer therapy in hepatocellular carcinoma cells

por Tomimaru, Y, Eguchi, H, Wada, H, Noda, T, Murakami, M, Kobayashi, S, Marubashi, S, Takeda, Y, Tanemura, M, Umeshita, K, Doki, Y, Mori, M, Nagano, H
Publicado 2010

miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1

por Iwagami, Y, Eguchi, H, Nagano, H, Akita, H, Hama, N, Wada, H, Kawamoto, K, Kobayashi, S, Tomokuni, A, Tomimaru, Y, Mori, M, Doki, Y
Publicado 2013

Activation of Wnt/β-catenin signalling pathway induces chemoresistance to interferon-α/5-fluorouracil combination therapy for hepatocellular carcinoma

por Noda, T, Nagano, H, Takemasa, I, Yoshioka, S, Murakami, M, Wada, H, Kobayashi, S, Marubashi, S, Takeda, Y, Dono, K, Umeshita, K, Matsuura, N, Matsubara, K, Doki, Y, Mori, M, Monden, M
Publicado 2009

Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-α and intra-arterial 5-fluorouracil; role of type 1 interfe...

por Ota, H, Nagano, H, Sakon, M, Eguchi, H, Kondo, M, Yamamoto, T, Nakamura, M, Damdinsuren, B, Wada, H, Marubashi, S, Miyamoto, A, Dono, K, Umeshita, K, Nakamori, S, Wakasa, K, Monden, M
Publicado 2005

MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer

por Hasegawa, S, Eguchi, H, Nagano, H, Konno, M, Tomimaru, Y, Wada, H, Hama, N, Kawamoto, K, Kobayashi, S, Nishida, N, Koseki, J, Nishimura, T, Gotoh, N, Ohno, S, Yabuta, N, Nojima, H, Mori, M, Doki, Y, Ishii, H
Publicado 2014

NY-ESO-1 antibody as a novel tumour marker of gastric cancer

por Fujiwara, S, Wada, H, Kawada, J, Kawabata, R, Takahashi, T, Fujita, J, Hirao, T, Shibata, K, Makari, Y, Iijima, S, Nishikawa, H, Jungbluth, A A, Nakamura, Y, Kurokawa, Y, Yamasaki, M, Miyata, H, Nakajima, K, Takiguchi, S, Nakayama, E, Mori, M, Doki, Y
Publicado 2013